LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novo Nordisk A/S ("Novo Nordisk†or "the Company†) (NYSE: NVO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Novo Nordisk is the subject of a report by CNBC published on February 23, 2026, titled: "N ...

记者丨黎雨桐 李益文 编辑丨倪新平 美国贸易政策前景不明令市场情绪承压，23日，美股三大指数集体低开，截至北京时间22：40，纳指跌 0.23%，道指跌0.05%，标普500指数跌0.02%。 | 美股指数 它 | | | | --- | --- | --- | | 道琼斯工业 | 纳斯达克指数 | 标普500 | | 49602.91 | 22833.70 | 6907.97 | | -23.06 -0.05% -52.37 -0.23% -1.54 -0.02% | | | | 美国科技七巨头 中概科技龙头 | | 中国金龙 | | 63149.24 | 4055.96 | 7568.77 | | -57.75 -0.09% +44.89 +1.12% +18.89 +0.25% | | | | 道琼斯期货 | 纳斯达克100期 | 标普500期货 | | 49495 | 24956.00 | 6904.00 | | -179 -0.36% -111.50 -0.44% -19.25 -0.28% | | | 科技股多数下跌，特斯拉跌超2%，亚马逊、微软跌近2%，脸书跌近1%。 欧洲减肥药巨头诺和诺德大跌 ...

诺和诺德(NVO.US)盘初大跌近16%，报39.97美元；礼来(LLY.US)盘初涨超4%，报1055.47美元。诺和诺 德称其减肥药物卡格列肽(Cagrisema)的实验效果不及礼来的替尔泊肽(Zepbound)。 ...

As you know, Novo Nordisk ( NVO ) has just released top-line results from its REDEFINE 4 Phase 3 obesity trial. Overall, the results are clearly a disappointment relative toI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind drug devel ...

2月23日，美国贸易政策前景不明令市场情绪承压，美股三大指数集体低开，纳指跌0.03%，道指跌 0.31%，标普500指数跌0.03%。 科技股普跌，特斯拉、甲骨文跌超1%。 诺和诺德大跌15%，该公司新一代减肥药CagriSema的试验效果不及礼来的Zepbound。 ...

联合航空跌1.7%、美国航空跌1.1%、达美航空跌1.5%，受特大暴风雪影响，航空公司被迫在全美范围 内取消航班。Arcellx涨78.1%，吉利德科学将以每股115美元的价格收购Arcellx。诺和诺德跌15.6%，其 减肥药CagriSema试验效果不及礼来的竞品，礼来涨4.8%。达美乐披萨涨6.0%，Q4营收超预期。 来源：滚动播报 ...

The Supreme Court's decision to strike down President Trump's reciprocal tariffs doesn't end his plans for pharmaceutical industry tariffs. Join us now. A former FDA commissioner uh Dr.. Scott Gotautle. He's a CNBC contributor. Serves on the boards of Aluminina, Fizer, and United Health. You you're not so sure, are you? Doesn't the pharmaceutical industry agreed to a lot of what uh the president wanted? and and are are future tariffs necessary at this point for for where President Trump wanted to go with wi ...

Ozempic drugmaker Novo Nordisk was once Europe’s most valuable company - George Frey/Reuters Almost £150bn has been wiped off Ozempic drugmaker Novo Nordisk after a trial of its new weight-loss drug fell short of expectations. Shares in the Danish pharmaceutical giant plunged by 15pc on Monday, wiping around €169bn (£147bn) off its market value in just 90 minutes. Trading was briefly halted in Copenhagen as a result of the sharp sell-off, which drove shares to their lowest level since 2021. It came af ...

Core Insights - Allka Research has over two decades of experience in investment, focusing on uncovering undervalued assets in ETFs, commodities, technology, and pharmaceutical sectors [1] - The company adopts a conservative investment approach, aiming to deliver substantial returns and strategic insights to clients [1] - Allka Research is committed to simplifying investment strategies, making them accessible to both seasoned and novice investors [1] Mission and Community Engagement - The company seeks to empower individuals financially by sharing its knowledge through Seeking Alpha, contributing analyses and informed perspectives [1] - Allka Research aims to demystify investing, fostering a community of informed investors who can navigate the markets intelligently [1] - The mission includes inspiring confidence in readers and promoting wealth creation through informed investment decisions [1]

Company Overview - Proactive is a financial news and online broadcast organization that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company operates across key finance and investing hubs with offices in London, New York, Toronto, Vancouver, Sydney, and Perth [2] Content Production - Proactive's editorial team produces approximately 50,000 pieces of real-time news, feature articles, and filmed interviews annually [1] - The content covers a wide range of topics, including medium and small-cap markets, blue-chip companies, commodities, biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Utilization - Proactive is committed to adopting technology to enhance workflows, utilizing both human expertise and technological tools [4] - The company employs automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans to maintain quality and best practices in content production [5]